[Federal Register Volume 83, Number 140 (Friday, July 20, 2018)]
[Notices]
[Pages 34589-34590]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-15526]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-18-1091]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Using Qualitative Methods to Understand
Issues in HIV Prevention, Care and Treatment in the United States'' to
the Office of Management and Budget (OMB) for review and approval. CDC
previously published a ``Proposed Data Collection Submitted for Public
Comment and Recommendations'' notice on March 13, 2018 to obtain
comments from the public and affected agencies. CDC received four
comments related to the previous notice. This notice serves to allow an
additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Using Qualitative Methods to Understand Issues in HIV Prevention,
Care and Treatment in the United States (OMB No. 0920-1091; expires
December 31, 2018)--Extension--National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC's National Center on HIV/AIDS, Viral Hepatitis, STD and TB
Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP) seeks a
three year extension for an existing Generic information collection
request (Generic ICR) entitled, ``Using Qualitative Methods to
Understand Issues in HIV Prevention, Care and Treatment in the United
States'' (OMB Number: 0920-1091). Specific studies conducted under this
extended Generic ICR will be consistent with the national HIV
prevention goals, the CDC Division of HIV/AIDS Prevention (DHAP)
Strategic Plan, and DHAP's High-impact HIV Prevention approach.
The purposes for each data collection study supported under this
extended Generic ICR will be to understand specific barriers and
facilitators to local HIV prevention, care and treatment in the United
States and territories. For example, each study will seek to identify
ways to improve programmatic activities along the continuum of HIV
prevention, treatment and care for different populations residing in
different geographic settings with greatest burden of HIV.
The target populations for studies included in this extended
Generic ICR include, but are not limited to: Persons living with HIV
who are in treatment; persons living with HIV who are out of treatment
and who may or may not be seeking treatment at healthcare facilities;
persons at high risk for HIV acquisition (HIV negative) and HIV
transmission (HIV positive); persons from groups at high risk for HIV
including gay, bisexual and other MSM, transgender persons, and
injection and non-injection drug users; persons from racial and ethnic
minorities; and healthcare providers or other professionals who provide
HIV prevention, care and treatment services. Other populations may
include individuals who provide non-HIV services or otherwise interact
with persons living with HIV or persons at risk for HIV acquisition.
Studies will only provide local contextual information about the
barriers and facilitators to HIV prevention, care, and treatment
experienced by specific communities at risk for acquiring HIV
infection, by HIV-positive persons across the HIV care continuum, and
by organizations or individuals providing HIV prevention, care,
treatment, and related support services.
Data collection methods used in any of the specific studies
primarily will consist of rapid qualitative assessment methodologies,
such as semi-structured and in-depth qualitative interviews, focus
groups; direct observations; document reviews; and short structured
surveys. Data will be analyzed using
[[Page 34590]]
well-established qualitative analysis methods, such as coding
interviews for themes about barriers and successes to HIV prevention,
care, and treatment. Structured response surveys will be analyzed using
descriptive statistics and other appropriate statistical methods.
CDC will use the results from each specific data collection study
to help to identify ways to improve local programmatic activities for
specific communities along the continuum of HIV prevention, treatment
and care for populations and areas with the greatest HIV burden. CDC
will communicate study outcomes to local stakeholders and organizations
in positions to consider and implement site-specific improvements in
HIV prevention, care, and treatment for each of the study sites
examined. For stakeholders, organizations, or agencies outside the
local affected communities, all communications will include clear
discussion of the limitations of the region-specific, qualitative
methods and the non-generalizability of the study outcomes.
For a given year, each separate data collection will range from 30
(minimum) to 200 (maximum) respondents based on the nature and scope of
the research purposes. For example, if there are three data
collections, the maximum combined number of expected respondents is
600. In a given year, CDC anticipates that the need to screen 1600
persons to identify 800 eligible persons, of which 600 persons will
agree to participate.
CDC anticipates that screener forms will take five minutes to
complete each, contact information forms will take one minute to
complete each, and consent forms will take five minutes to complete
each. CDC anticipates 50% of the targeted populations screened will be
eligible for the study. Of eligible persons, 75% will agree to
participate.
Brief structured surveys will take 15 minutes to complete. In-depth
interviews or focus groups with respondents are expected to take 60
minutes (one hour) to complete. In-depth interviews or focus groups
with healthcare providers are expected to take 45 minutes to complete.
The total annual response burden based on an average of 600 study
respondents per year (assuming three large data collections involving
200 participants each) is estimated at 918 hours. There is no cost to
respondents other than their time.
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
General Public--Adults................ Study Screener.......... 1600 1 5/60
General Public--Adults................ Contact Information Form 600 1 1/60
General Public--Adults................ Consent Form............ 600 1 5/60
General Public--Adults................ Demographic Survey...... 500 1 15/60
General Public--Adults................ Interview Guide......... 500 1 1
General Public--Adults................ Provider Demographic 100 1 15/60
Survey.
General Public--Adults................ Provider Interview Guide 100 1 45/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Chief, Information Collection Review Office, Office of
Scientific Integrity, Office of the Associate Director for Science,
Office of the Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-15526 Filed 7-19-18; 8:45 am]
BILLING CODE 4163-18-P